Mohamad Makhzoumi - Insider Trading & Ownership

Entity
Individual
Location
2855 Sand Hill Road, Menlo Park, CA
Summary
The estimated net worth of Mohamad Makhzoumi is at least $322M dollars as of October 3, 2024. Mohamad Makhzoumi is the 10%+ Owner of Monte Rosa Therapeutics, Inc. and owns shares of Monte Rosa Therapeutics, Inc. (GLUE) stock worth about $146M. Mohamad Makhzoumi is the 10%+ Owner of Savara Inc and owns shares of Savara Inc (SVRA) stock worth about $109M. Mohamad Makhzoumi is the 10%+ Owner of Korro Bio, Inc. and owns shares of Korro Bio, Inc. (KRRO) stock worth about $61.1M. Mohamad Makhzoumi is the Director, 10%+ Owner of NeueHealth, Inc. and owns shares of NeueHealth, Inc. (NEUE) stock worth about $2.3M. Mohamad Makhzoumi is the 10%+ Owner of Trevi Therapeutics, Inc. and owns shares of Trevi Therapeutics, Inc. (TRVI) stock worth about $1.92M. Mohamad Makhzoumi is the 10%+ Owner of Metacrine, Inc. and owns shares of Metacrine, Inc. stock worth about $1.2M. Mohamad Makhzoumi is the 10%+ Owner of Mirum Pharmaceuticals, Inc. and owns shares of Mirum Pharmaceuticals, Inc. (MIRM) stock worth about $318K. Mohamad Makhzoumi is the Director of Robinhood Markets, Inc. and owns shares of Robinhood Markets, Inc. (HOOD) stock worth about $78.3K. Mohamad Makhzoumi is the 10%+ Owner of IonQ, Inc. and owns shares of IonQ, Inc. (IONQ) stock worth about $35.7K. Mohamad Makhzoumi is the 10%+ Owner of Arcellx, Inc. and owns shares of Arcellx, Inc. (ACLX) stock worth about $15.6K. Mohamad Makhzoumi is the 10%+ Owner of AVEO PHARMACEUTICALS, INC. and owns shares of AVEO PHARMACEUTICALS, INC. stock worth about $13.7K. Mohamad Makhzoumi is the 10%+ Owner of Desktop Metal, Inc. and owns shares of Desktop Metal, Inc. (DM) stock worth about $1.52K.
All Insider Reports
All Insider Reports

Ownership of Mohamad Makhzoumi

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
GLUE Monte Rosa Therapeutics, Inc. 10%+ Owner $146M Jun 28, 2021
SVRA Savara Inc 10%+ Owner $109M Jul 17, 2023
KRRO Korro Bio, Inc. 10%+ Owner $61.1M +$1M +1.66% Apr 22, 2024
NEUE NeueHealth, Inc. Director, 10%+ Owner $2.3M Oct 1, 2024
TRVI Trevi Therapeutics, Inc. 10%+ Owner $1.92M Apr 11, 2022
MTCR Metacrine, Inc. 10%+ Owner $1.2M Dec 10, 2021
MIRM Mirum Pharmaceuticals, Inc. 10%+ Owner $318K Jun 13, 2023
HOOD Robinhood Markets, Inc. Director $78.3K May 2, 2022
IONQ, IONQ-WT IonQ, Inc. 10%+ Owner $35.7K Nov 16, 2022
ACLX Arcellx, Inc. 10%+ Owner $15.6K Dec 20, 2022
AVEO AVEO PHARMACEUTICALS, INC. 10%+ Owner $13.7K Oct 19, 2022
DM Desktop Metal, Inc. 10%+ Owner $1.52K Jun 8, 2021
AKUS Akouos, Inc. 10%+ Owner Nov 30, 2022
EAR Eargo, Inc. 10%+ Owner May 24, 2021
GNCA GENOCEA BIOSCIENCES, INC. 10%+ Owner May 24, 2022
MBX MBX Biosciences, Inc. 10%+ Owner Sep 16, 2024

Insider Transactions Reported by Mohamad Makhzoumi:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.